ABBOTT LABORATORIES (ABT) revenue & profit

ABBOTT LABORATORIES (ABT): revenue $44.3B, net income $6.5B in 2025; latest quarter +13% year over year. From SEC filings.

$44.3BRevenue 2025

TickerABT (NYSE)

IndustryHealthcare · Pharmaceutical Preparations

Revenue 2025$44.3B

Net income 2025$6.5B

Net margin14.7%

Annual revenue growth+5.7%

Latest quarter (2026 Q2) · Revenue$12.6B

vs. same quarter last year+13%

Latest quarter · Net income$928M

Annual revenue & net income

Year	Revenue	Net income
2022	$43.7B	$6.9B
2023	$40.1B	$5.7B
2024	$42B	$13.4B
2025	$44.3B	$6.5B

ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.

↗ Official filings on SEC EDGAR

📷 Logo is a trademark of its owner · Abbott Laboratories · Public domain · Wikimedia Commons

About this data

Figures come from the financial statements U.S.-listed companies file with the Securities and Exchange Commission (SEC EDGAR, XBRL data). We use reported annual and quarterly revenue and net income and compare them with the same period a year earlier to calculate growth.

Companies use different fiscal years and sometimes restate past results, and one-off items can make net income jump. This page is for information only and is not investment advice.